Lyser D Tablet contains a combination of Diclofenac 50 mg and Serratiopeptidase 10 mg, formulated to provide effective relief from pain and inflammation. Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing the synthesis of prostaglandins responsible for inflammation, pain, and fever. Serratiopeptidase is a proteolytic enzyme that facilitates the breakdown of inflammatory mediators and promotes the resolution of inflammation by enhancing tissue repair and reducing edema. This synergistic combination is commonly prescribed for managing acute and chronic inflammatory conditions such as musculoskeletal disorders, postoperative pain, rheumatoid arthritis, osteoarthritis, and soft tissue injuries. Lyser D Tablet is effective in alleviating pain, swelling, and stiffness, improving patient mobility and quality of life. It should be used under medical supervision, with caution advised in patients with gastrointestinal ulcers, bleeding disorders, hepatic or renal impairment, and hypersensitivity to NSAIDs or serratiopeptidase. The medication is typically administered orally, with dosage and duration tailored to the severity of the condition and patient response. Adverse effects may include gastrointestinal discomfort, nausea, or allergic reactions, and patients should report any unusual symptoms promptly to their healthcare provider.